New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.

Data demonstrate potent suppression of MAPK signaling and viability in KRAS mutant cell lines, as well as anti-tumor activity across multiple ...

Researchers have understood for decades that some forms of deafness are inherited, yet until now, few of those genetic clues ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Telomir Pharmaceuticals (TELO) reported new preclinical data from an in vivo study in mice bearing human aggressive prostate cancer tumors ...

First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating ...

Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a ...

This review systematically examines the potential of spices and culinary herbs (e.g., turmeric, garlic, ginger) for breast cancer (BC) prevention and treatment, elucidating their underlying mechanisms ...

The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On October 22, 2025, Telomir Pharmaceuticals announced preclinical ...